2.30
前日終値:
$1.97
開ける:
$2.01
24時間の取引高:
1.20M
Relative Volume:
3.46
時価総額:
$137.79M
収益:
$8.38M
当期純損益:
$-27.19M
株価収益率:
-2.1101
EPS:
-1.09
ネットキャッシュフロー:
$-13.59M
1週間 パフォーマンス:
+15.58%
1か月 パフォーマンス:
+39.39%
6か月 パフォーマンス:
+142.11%
1年 パフォーマンス:
+91.67%
Opus Genetics Inc Stock (IRD) Company Profile
IRD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
IRD
Opus Genetics Inc
|
2.30 | 118.02M | 8.38M | -27.19M | -13.59M | -1.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Opus Genetics Inc Stock (IRD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-29 | 開始されました | Wedbush | Outperform |
| 2025-10-16 | 開始されました | Chardan Capital Markets | Buy |
| 2025-04-11 | 開始されました | Craig Hallum | Buy |
| 2024-11-13 | 再開されました | H.C. Wainwright | Buy |
Opus Genetics Inc (IRD) 最新ニュース
Will Opus Genetics Inc. stock continue upward momentumJuly 2025 Trends & Growth Oriented Trade Recommendations - newser.com
Identifying reversal signals in Opus Genetics Inc.Trade Risk Summary & Low Drawdown Trading Strategies - newser.com
What the charts say about Opus Genetics Inc. today2025 Year in Review & Reliable Entry Point Trade Alerts - newser.com
Is Opus Genetics Inc. stock ready for a breakoutJuly 2025 News Drivers & Free High Accuracy Swing Entry Alerts - newser.com
Is Opus Genetics Inc a good long term investmentSupport and Resistance Levels & Stay Invested. Stay Smart. - earlytimes.in
Does Opus Genetics Inc. stock trade at a discount to peersQuarterly Risk Review & Smart Money Movement Alerts - newser.com
How to use a screener to detect Opus Genetics Inc. breakoutsPortfolio Risk Summary & Free Technical Pattern Based Buy Signals - newser.com
Using Ichimoku Cloud for Opus Genetics Inc. technicalsJuly 2025 Technicals & Expert Curated Trade Setup Alerts - newser.com
Will Opus Genetics Inc. stock benefit from infrastructure spendingJuly 2025 EndofMonth & Low Drawdown Momentum Ideas - newser.com
Can Opus Genetics Inc. hit a new high this monthGlobal Markets & High Accuracy Buy Signal Tips - newser.com
Why Opus Genetics Inc. stock is in analyst buy zonePortfolio Growth Summary & Momentum Based Trading Signals - newser.com
Can Opus Genetics Inc. (R3X1) stock sustain institutional flowsTrade Analysis Summary & Stepwise Trade Signal Guides - newser.com
Can Opus Genetics Inc. stock hit analyst price targetsJuly 2025 Drop Watch & Verified Technical Trade Signals - newser.com
What MACD trends signal for Opus Genetics Inc. (R3X1) stockJuly 2025 Review & Fast Gaining Stock Reports - newser.com
Is Opus Genetics Inc. stock attractive for hedge fundsJuly 2025 Highlights & Real-Time Buy Signal Notifications - newser.com
Can Opus Genetics Inc. (R3X1) stock attract ESG investmentsBond Market & Weekly Return Optimization Alerts - newser.com
With Opus Genetics Up 16%, Insider Buyers Count Their Returns - Yahoo Finance
Q3 Earnings Forecast for Opus Genetics Issued By Wedbush - MarketBeat
What candlestick patterns are forming on Opus Genetics Inc.July 2025 Drop Watch & Reliable Price Breakout Alerts - newser.com
Price action breakdown for Opus Genetics Inc.Weekly Stock Recap & Scalable Portfolio Growth Ideas - newser.com
Is Opus Genetics Inc. stock a safe haven assetRecession Risk & High Return Stock Watch Alerts - newser.com
Published on: 2025-11-01 00:17:29 - newser.com
Opus Genetics, Inc. (NASDAQ:IRD) Sees Large Increase in Short Interest - MarketBeat
Opus Genetics (NASDAQ:IRD) Trading Up 2.6%Still a Buy? - MarketBeat
Is Opus Genetics Inc. (R3X1) stock ideal for retirement investorsCEO Change & Smart Money Movement Alerts - newser.com
Opus Genetics (IRD) Price Target Decreased by 15.00% to 6.94 - MSN
Opus Genetics Inc R3X1 Stock Analysis and ForecastVolume Spike Alerts & Plan Your Exit as You Enter – Risk First - earlytimes.in
Wedbush Initiates Coverage on Opus Genetics (NASDAQ:IRD) - MarketBeat
Opus Genetics Advances Gene Therapy for Retinal Degeneration: A Study Update - MSN
Wedbush Initiates Coverage of Opus Genetics (IRD) with Outperform Recommendation - MSN
Opus Genetics Inc (IRD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):